Patent Assignment
Reel/Frame 049613/0472
Assignment of Assignor's Interest
Recorded: 2019-06-27
Pages: 9
Assignor
TABUTEAU, HERRIOT
Executed: 2019-06-20
Assignee
AXSOME THERAPEUTICS, INC.
200 BROADWAY, 3RD FLOOR, NEW YORK, NEW YORK, 10038
Covered Properties
(15)
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
Application:
16/362,434 →
Publication:
US 2020/0093760
Neridronic Acid and Other Bisphosphonates for Treating Complex Regional Pain Syndrome and Other Diseases
Application:
16/365,459 →
Publication:
US 2019/0216728
Neridronic Acid and Other Bisphosphonates for Treating Complex Regional Pain Syndrome and Other Diseases
Application:
16/366,207 →
Publication:
US 2019/0216832
Combination of Dextromethorphan and Bupropion for Treating Depression
Application:
62/789,431 →
Combination of Dextromethorphan and Bupropion for Treating Depression
Application:
62/789,446 →
Combination of Dextromethorphan and Bupropion for Treating Depression
Application:
62/789,451 →
Combination of Dextromethorphan and Bupropion for Treating Depression
Application:
62/789,488 →
Neridronic Acid and Other Bisphosphonates for Treating Complex Regional Pain Syndrome and Other Diseases
Application:
62/802,107 →
Meloxicam and Rizatriptan for Treating Migraine
Application:
62/802,198 →
Pharmaceutical Compositions Comprising Meloxicam
Application:
62/803,756 →
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
Application:
62/810,880 →
Combination Treatment for Migraine and Other Pain
Application:
62/835,613 →
Compositions for Delivery of Reboxetine
Application:
62/837,002 →
Dosage Forms Comprising Active Pharmaceutical Ingredients
Application:
62/842,394 →
Combination Treatment for Migraine and Other Pain
Application:
62/846,311 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Intellectual Property Security Agreement
Sep 25, 2020
From: AXSOME THERAPEUTICS, INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 053941/0491 →
Assignment of Assignor's Interest
Feb 19, 2021
From: AXSOME THERAPEUTICS, INC.
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 055341/0965 →
Security Interest
May 9, 2025
From: AXSOME THERAPEUTICS, INC.; AXSOME MALTA LTD.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 071247/0836 →
Release of Security Interest
May 22, 2025
From: HERCULES CAPITAL, INC.
To: AXSOME THERAPEUTICS, INC.
Reel/Frame 071337/0004 →